U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07224139) titled 'Sex-specific Risk Factors and Trajectories of Blood Biomarkers for Alzheimer's Disease and Related Dementias' on Oct. 31.
Brief Summary: Blood-based ADRD biomarkers show tremendous promise as a non-invasive method to predict and diagnose ADRD. We will measure changes in these biomarkers to determine whether their ability to predict ADRD differs by sex or by other characteristics, and develop a sex-specific ADRD risk score for personalized medicine and clinical trials.
Study Start Date: July 01, 2022
Study Type: OBSERVATIONAL
Condition:
Alzheimer Disease
Dementia
Cognitive Dysfunction
Recruitment Status: ACTIVE_NOT_RECRUITING
Sp...